VKH
JNP

Virtu KCG Holdings’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Virtu KCG Holdings’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-23,544
Closed -$112K – 3810
2017
Q1 		$112K Buy
+23,544
New +$119K ﹤0.01% 2651
2015
Q2 		– Sell
-11,228
Closed -$70K – 3985
2015
Q1 		$70K Buy
+11,228
New +$69.5K ﹤0.01% 2744

Other funds holding JNP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
MERSOM
Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Virtu KCG Holdings's JNP Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q2 2017, closing a stake of 23,544 shares — an estimated $112K sold.

Virtu KCG Holdings first reported a position in JNP in Q1 2015 and held it in 2 quarters. The position peaked at $112K in Q1 2017. 33 funds tracked by Wall St. Rank hold JNP as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 23,544 Juniper Pharmaceuticals, Inc. Common Stock shares in Q2 2017, an estimated $112K.
  • Virtu KCG Holdings first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2015 and held it in 2 quarters.
  • Virtu KCG Holdings's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $112K in Q1 2017.
  • 33 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.